Multicenter analysis of lymph node metastasis distribution patterns in patients with anal carcinoma and optimization of radiotherapy target volume delineation using ProKnow

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00037793

Enrollment

300

Registered

2025-09-16

Start date

2025-07-23

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C21.0

Interventions

Group 1: Estimation of a spatial probability distribution for the occurrence of lymph node metastases in patients treated with definitive radio(chemo)therapy for anal carcinoma

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Histologically proven anal cancer” Definitive radio(chemo)therapy

Exclusion criteria

Exclusion criteria: Age < 18 years

Design outcomes

Primary

Measure	Time frame
Retrospective estimation of a spatial probability distribution for the occurrence of lymph node metastases in patients treated with definitive radio(chemo)therapy for anal carcinoma between January 1, 2008, and June 15, 2025	—

Secondary

Measure	Time frame
Optimization of elective radiotherapy target volume definition	—

Countries

Germany

Contacts

Public ContactFranziska Walter

Klnik und Poliklinik für Strahlentherapie und Radioonkologie, LMU Klinikum

franziska.walter@med.uni-muenchen.de+49 89440073770

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026